tirzepatide semaglutide comparison versus Once Weekly in Patients with Type 2 Diabetes Tirzepatide vs Semaglutide for Weight
Description
Int J Numer Method Biomed Eng
A testslycskkentst clz gygyszeres terpia sosem elegend nmagban
Semaglutide is a GLP-1 receptor agonist available as weekly injection (Ozempic for diabetes, Wegovy for weight management) or daily oral tablet (Rybelsus for diabetes only)
Studies suggest patients may lose up to about 20 pounds in two months and up to 40 pounds in four months, and the program can be repeated if desired
Its injectable counterpart is sold as Ozempic
These drugs may also provide neuroprotective effects in cognitively healthy people living with diabetes (Hlscher, 2022
